550e20759a6664aeb52f198a164aca0452f70b6e136cf3ddb783fbe74ef92a6b 218776 data/Rdata.rdb
9eac1c572a95aadfa68ac29d39d74180b7aee5771af1cc921891c77f3e8c87c3 104 data/Rdata.rds
2e4d3e355e3d657a13e3096cb1c4c6d8962937b0148c0f29c4b79b983dbc3ee4 174 data/Rdata.rdx
92ff8388cd094eea314462775da6b21171cf30a824d31f69997409715c16c35b 2368 DESCRIPTION
3eaa3f9fd8148b5e0cef28f9a33d2adfe2de80ac1f15ad91a59bdc8c6fb34cce 2502 doc/index.html
e24468b54be9cc84bd4f0cc21e2c0bc8025c2cc4f72c127df6936623fbec8d3b 113420 doc/library_abstinence_20220711.html
ad1617f5fc94816509ffb4945ba1fb4219cada16345c5558badc6a20d335a507 12850 doc/library_abstinence_20220711.R
461bd38e329edc57efe4f6f45aea2351fe76e67c628de589dce869affd222180 17603 doc/library_abstinence_20220711.Rmd
9465f4e9c54ece17eb32e18cfe6ba71fe37a2f54f2dff1dcc4694218bc7dc2ce 241536 doc/library_reduction_20220630.html
c1eace532efcc99caabcb929f8d67b5c4d2033745dcf18ef55e8484d256f19df 29426 doc/library_reduction_20220630.R
f0193e153cb20bc069bacb4d9f453d2a0376bb7c92c436dee49d6f249b950f97 36110 doc/library_reduction_20220630.Rmd
e475ac857ce5606b3c8aa27419fdbce28c7bf2236748f667e7e5d3bb1a51c513 70756 doc/library_relapse_20220711.html
8fe4bb81b9e6893a6524d852a86384fbca3c3d844944daafb9fdd418f0a5a5d1 7446 doc/library_relapse_20220711.R
f9c7049b39f703e0c3478a31a0360f91f6883599e87d7539ca8bf146d5fe6183 10238 doc/library_relapse_20220711.Rmd
4a66b186f7d31d33c10e53c5fae66bef4d4703ae1d5fb98e108e5296398694ad 283183 extdata/outcomes_abstinence_20220818.csv
ab6e7b64b2b6f3c2e2460a5d6f0ac611e8b7352df2294bdffebf1ddf745da115 1143076 extdata/outcomes_reduction_20220818.csv
cc25439ca52c9f8395cc1053e0c407f44c25dfd181d6cec39d441ab0e092d104 216723 extdata/outcomes_relapse_20220818.csv
6095ab018c06d3d333b3de33f9384761afe28210af841e6644414aa4eb32554b 244 help/aliases.rds
22d855a475d89f2d7ddafa0aefa9c3acda2fb9465c4f1fe1768d42d1acf960fc 452 help/AnIndex
dd8642c07aa701b52e5069f61065b21ad9e9929602cc6490e932d1fd71c49cf2 39853 help/CTNote.rdb
4c4dec00c7c421d336cd806aeb367042bd4fb512a0301dc74538733fc8893e48 493 help/CTNote.rdx
2fb576659418ed3ffa87d92b5c587b596a3be2d7420ae768633b4feb6fbbff83 315 help/paths.rds
80eea168db9479f917ccbdf2bb43bf05cede99e70d5ac30e0b82944c4d7ece28 2959 html/00Index.html
3d290675266eebeba6efff07db879d699843c80bf428f9e71000e2fc6078f5db 2133 html/R.css
ac55ae1bb88f80e27fbc7f27170390c74be75b8c883c03d175b73a6f7f575fbc 1009 INDEX
9ae16654a4b399c7a8479f1babfbee0d67f0312502c2098ed93a945cf3a7f8b2 175 Meta/data.rds
4b4f4bdc2af5fcaf69e01a9619a9e13389269852740c5fba1fcb2bf0ae963dd8 122 Meta/features.rds
7282bb3758ed8c6874c31245b071abe87128abfa350910e779622d3a49e6d35e 752 Meta/hsearch.rds
184aed0dd8a88219ccabce7e33f5ec248fa2702fb53e84511445cdb1de23f97b 330 Meta/links.rds
4e35fa7ccbd7863d9b8a7ef78abc3e390e73e69ecce41560dc16c2bf06970e75 391 Meta/nsInfo.rds
49920b1087de7aa8441043af0bf0fb9dc54ab0a9e6caf90e518f36417ee99dd9 1615 Meta/package.rds
36bac94414d881598f793646b1d3c1f0581f4bfce01714c9a88dd367e08bbca7 776 Meta/Rd.rds
b0a8c5ad20033ff43e456fcfe8ff576822dfbb97201f78185ce0cf241e3280ff 304 Meta/vignette.rds
08de45475372f71b15a13a82a94731d3252f51334d2b3c72aa7c93e7afa45618 574 NAMESPACE
8de869e94e8f363e06cf79b3951c1882e71610e1e626e87deb4ddde68084683a 159 NEWS.md
570ca456b280cdeb201ef5ebdf22dc8f80092e2c0c68e33c7f73340e420f3759 1058 R/CTNote
035f5827c552eae93437e33b7fdd0a0ca82e2f1b1f300e4e445cd02763e7a2b3 16439 R/CTNote.rdb
f38781e6a280a2460750a90062b8662e279853ce22487fd959c288520eedb81b 505 R/CTNote.rdx
523810fa0667d1699d1e25b51ac5615e48be249a9ea0b8fa5fa0fb6de3bc7238 3270 README.md
5574d700eb016948e9728709ceba7cb3bc3d57485bf24ca0168ab2c60918e00d 496 scripts/create_allDrugs_opioid_subset_20220916.R
f222e614bf2db411ab883e626c2025f3eaa22a125838d34a0427bedf77d15c99 852 scripts/create_outcomes_table_20220818.R
ee4039b2f6802c7748c25d9f1f2ed37d0dcaf88ea7f20bbff6e497dc67c6fb20 82597 suppl_docs/brandt_treatment_outcomes_20211222.docx
cc5efe361b3ae5bb9fb1e885096a144e00cc38e04bf67a34063821dff4c33dfe 16906 suppl_docs/definitions_20220405.xlsx
